Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2011 October;52(5) > The Journal of Cardiovascular Surgery 2011 October;52(5):701-16

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

  NEW TECHNOLOGIES IN SFA STENTING


The Journal of Cardiovascular Surgery 2011 October;52(5):701-16

Copyright © 2011 EDIZIONI MINERVA MEDICA

lingua: Inglese

Infrainguinal disease treatment: to stent or not to stent

Dosluoglu H. H. 1, Lall P. 2

1 Division of Vascular Surgery, VA Western NY Healthcare System, Buffalo, NY, USA;
2 Division of Vascular Surgery, Department of Surgery, State University of New York at Buffalo, Buffalo, NY, USA


PDF  


Infrainguinal endovascular interventions have increasingly played a central role in relieving symptoms of claudication and limb salvage over the last decade. Multiple modalities currently exist for treating these arteries; however, balloon angioplasty with or without stenting still remains the most commonly used technique. Despite the concerns regarding the use of stents with stent fractures and in-stent restenosis, there is increased evidence from randomized and non-randomized studies that use of nitinol stents improves patency rates in most patients with >5 cm long lesions. However, the optimal endovascular treatment of the longest lesions is still debated. Infrapopliteal vessels are still mostly treated with balloon angioplasty, but selective use of bare or drug eluting stents especially in longer lesions is promising. The role of drug-eluting stents, balloons and other debulking procedures for both femoropopliteal and infrapopliteal arteries still needs to be further investigated.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

dosluoglu@yahoo.com